The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Neuromodulation Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Neuromodulation devices are medical tools used to modulate the activity of the nervous system. They operate by delivering electrical, magnetic, or pharmaceutical stimuli to specific neural targets in order to alleviate symptoms of neurological and psychiatric disorders, manage pain, or enhance cognitive functions. These devices are designed to offer alternative and effective treatment options for patients who have not responded well to conventional therapies or medications.
Common types of neuromodulation devices include:
1. Deep Brain Stimulation (DBS) Devices: DBS devices involve the implantation of electrodes within specific areas of the brain to deliver electrical stimulation. They are utilized to treat conditions such as Parkinson's disease, essential tremor, and dystonia.
2. Spinal Cord Stimulation (SCS) Devices: SCS devices send electrical impulses to the spinal cord to alleviate chronic pain, particularly in cases where other treatments have not been effective.
3. Transcranial Magnetic Stimulation (TMS) Devices: TMS devices use magnetic fields to stimulate specific areas of the brain and are employed as an alternative treatment for depression and certain psychiatric disorders.
4. Sacral Neuromodulation Devices: These devices are used to manage urinary incontinence, urinary retention, and fecal incontinence by delivering electrical stimulation to the sacral nerves.
Neuromodulation devices strive to improve the quality of life for patients suffering from various neurological and psychiatric conditions. They are developed based on ongoing research and technological advancements in the fields of neuroscience and medical engineering. However, it is crucial for physicians and patients to thoroughly evaluate the potential benefits and risks associated with the use of these devices to ensure safe and effective treatment.
This report aims to provide a comprehensive presentation of the global market for Neuromodulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation Devices.
Report Scope
The Neuromodulation Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuromodulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuromodulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Medtronic
- Boston Scientific
- Abbott
- LivaNova
- Nevro
- NeuroPace
- Beijing Pins
- Synapse Biomedical
Segment by Type
- Deep Brain Stimulation (DBS)
- Spinal Cord Stimulation (SCS)
- Vagus Nerve Stimulation (VNS)
- Sacral Nerve Stimulation (SNS)
- Gastric Electrical Stimulation (GES)
Segment by Application
- Pain Management
- Parkinson’s Disease
- Urinary and Fecal Incontinence
- Epilepsy
- Gastroparesis
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuromodulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuromodulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Neuromodulation Devices Market Overview
1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Neuromodulation Devices Segment by Type
1.2.1 Global Neuromodulation Devices Market Value Comparison by Type (2024-2030)
1.2.2 Deep Brain Stimulation (DBS)
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Vagus Nerve Stimulation (VNS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Gastric Electrical Stimulation (GES)
1.3 Neuromodulation Devices Segment by Application
1.3.1 Global Neuromodulation Devices Market Value by Application: (2024-2030)
1.3.2 Pain Management
1.3.3 Parkinson’s Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Global Neuromodulation Devices Market Size Estimates and Forecasts
1.4.1 Global Neuromodulation Devices Revenue 2019-2030
1.4.2 Global Neuromodulation Devices Sales 2019-2030
1.4.3 Global Neuromodulation Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neuromodulation Devices Market Competition by Manufacturers
2.1 Global Neuromodulation Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neuromodulation Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neuromodulation Devices Average Price by Manufacturers (2019-2024)
2.4 Global Neuromodulation Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuromodulation Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuromodulation Devices, Product Type & Application
2.7 Neuromodulation Devices Market Competitive Situation and Trends
2.7.1 Neuromodulation Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neuromodulation Devices Players Market Share by Revenue
2.7.3 Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuromodulation Devices Retrospective Market Scenario by Region
3.1 Global Neuromodulation Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neuromodulation Devices Global Neuromodulation Devices Sales by Region: 2019-2030
3.2.1 Global Neuromodulation Devices Sales by Region: 2019-2024
3.2.2 Global Neuromodulation Devices Sales by Region: 2025-2030
3.3 Global Neuromodulation Devices Global Neuromodulation Devices Revenue by Region: 2019-2030
3.3.1 Global Neuromodulation Devices Revenue by Region: 2019-2024
3.3.2 Global Neuromodulation Devices Revenue by Region: 2025-2030
3.4 North America Neuromodulation Devices Market Facts & Figures by Country
3.4.1 North America Neuromodulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neuromodulation Devices Sales by Country (2019-2030)
3.4.3 North America Neuromodulation Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuromodulation Devices Market Facts & Figures by Country
3.5.1 Europe Neuromodulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neuromodulation Devices Sales by Country (2019-2030)
3.5.3 Europe Neuromodulation Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuromodulation Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Neuromodulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neuromodulation Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Neuromodulation Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neuromodulation Devices Market Facts & Figures by Country
3.7.1 Latin America Neuromodulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neuromodulation Devices Sales by Country (2019-2030)
3.7.3 Latin America Neuromodulation Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuromodulation Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuromodulation Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neuromodulation Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neuromodulation Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neuromodulation Devices Sales by Type (2019-2030)
4.1.1 Global Neuromodulation Devices Sales by Type (2019-2024)
4.1.2 Global Neuromodulation Devices Sales by Type (2025-2030)
4.1.3 Global Neuromodulation Devices Sales Market Share by Type (2019-2030)
4.2 Global Neuromodulation Devices Revenue by Type (2019-2030)
4.2.1 Global Neuromodulation Devices Revenue by Type (2019-2024)
4.2.2 Global Neuromodulation Devices Revenue by Type (2025-2030)
4.2.3 Global Neuromodulation Devices Revenue Market Share by Type (2019-2030)
4.3 Global Neuromodulation Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neuromodulation Devices Sales by Application (2019-2030)
5.1.1 Global Neuromodulation Devices Sales by Application (2019-2024)
5.1.2 Global Neuromodulation Devices Sales by Application (2025-2030)
5.1.3 Global Neuromodulation Devices Sales Market Share by Application (2019-2030)
5.2 Global Neuromodulation Devices Revenue by Application (2019-2030)
5.2.1 Global Neuromodulation Devices Revenue by Application (2019-2024)
5.2.2 Global Neuromodulation Devices Revenue by Application (2025-2030)
5.2.3 Global Neuromodulation Devices Revenue Market Share by Application (2019-2030)
5.3 Global Neuromodulation Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Neuromodulation Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Neuromodulation Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Neuromodulation Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Corporation Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova Neuromodulation Devices Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Nevro
6.5.1 Nevro Corporation Information
6.5.2 Nevro Description and Business Overview
6.5.3 Nevro Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nevro Neuromodulation Devices Product Portfolio
6.5.5 Nevro Recent Developments/Updates
6.6 NeuroPace
6.6.1 NeuroPace Corporation Information
6.6.2 NeuroPace Description and Business Overview
6.6.3 NeuroPace Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeuroPace Neuromodulation Devices Product Portfolio
6.6.5 NeuroPace Recent Developments/Updates
6.7 Beijing Pins
6.6.1 Beijing Pins Corporation Information
6.6.2 Beijing Pins Description and Business Overview
6.6.3 Beijing Pins Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Pins Neuromodulation Devices Product Portfolio
6.7.5 Beijing Pins Recent Developments/Updates
6.8 Synapse Biomedical
6.8.1 Synapse Biomedical Corporation Information
6.8.2 Synapse Biomedical Description and Business Overview
6.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Synapse Biomedical Neuromodulation Devices Product Portfolio
6.8.5 Synapse Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuromodulation Devices Industry Chain Analysis
7.2 Neuromodulation Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuromodulation Devices Production Mode & Process
7.4 Neuromodulation Devices Sales and Marketing
7.4.1 Neuromodulation Devices Sales Channels
7.4.2 Neuromodulation Devices Distributors
7.5 Neuromodulation Devices Customers
8 Neuromodulation Devices Market Dynamics
8.1 Neuromodulation Devices Industry Trends
8.2 Neuromodulation Devices Market Drivers
8.3 Neuromodulation Devices Market Challenges
8.4 Neuromodulation Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
